China Resources Boya Bio-pharmaceutical Group Co.,Ltd

SZSE:300294 주식 보고서

시가총액: CN¥15.8b

China Resources Boya Bio-pharmaceutical GroupLtd 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Xiaoming Liang

최고 경영자

CN¥4.0m

총 보상

CEO 급여 비율n/a
CEO 임기3.8yrs
CEO 소유권n/a
경영진 평균 재임 기간3.3yrs
이사회 평균 재임 기간2.9yrs

최근 관리 업데이트

Recent updates

Investors Can Find Comfort In China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Earnings Quality

Nov 01
Investors Can Find Comfort In China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Earnings Quality

A Look At The Intrinsic Value Of China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)

Oct 01
A Look At The Intrinsic Value Of China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)

Market Participants Recognise China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) Earnings

Sep 12
Market Participants Recognise China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) Earnings

Does China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Have A Healthy Balance Sheet?

Jul 25
Does China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Have A Healthy Balance Sheet?

China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) P/E Is On The Mark

Jun 12
China Resources Boya Bio-pharmaceutical Group Co.,Ltd's (SZSE:300294) P/E Is On The Mark

China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Is Increasing Its Dividend To CN¥0.30

Apr 26
China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Is Increasing Its Dividend To CN¥0.30

Is China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Using Too Much Debt?

Apr 22
Is China Resources Boya Bio-pharmaceutical GroupLtd (SZSE:300294) Using Too Much Debt?

China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Conservative Accounting Might Explain Soft Earnings

Apr 01
China Resources Boya Bio-pharmaceutical GroupLtd's (SZSE:300294) Conservative Accounting Might Explain Soft Earnings

What Does The Future Hold For China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)? These Analysts Have Been Cutting Their Estimates

Mar 31
What Does The Future Hold For China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SZSE:300294)? These Analysts Have Been Cutting Their Estimates

CEO

Xiaoming Liang (57 yo)

3.8yrs

테뉴어

CN¥4,017,400

보상

Mr. Xiaoming Liang serves as Non-Independent Director at Boya Bio-pharmaceutical Group Co., Ltd since February 03, 2021 and also serves as a President. He is a member of the first session of the Biotechnol...


리더십 팀

이름위치테뉴어보상소유권
Xiaoming Liang
President & Directorno dataCN¥4.02m데이터 없음
Huacheng Liang
VP, CFO2.9yrsCN¥1.69m데이터 없음
Bing Chen
Vice President3.8yrsCN¥6.54m0.014%
CN¥ 2.2m
Shousun Ii
Vice President3.8yrsCN¥2.48m데이터 없음
Shuanhong Zhang
Vice President2.3yrsCN¥1.27m데이터 없음

3.3yrs

평균 재임 기간

47yo

평균 연령

경험이 풍부한 관리: 300294 의 관리팀은 경험 ( 3.3 년 평균 재직 기간)으로 간주됩니다.


이사회 구성원

이름위치테뉴어보상소유권
Xiaoming Liang
President & Director3.8yrsCN¥4.02m데이터 없음
Huacheng Liang
VP, CFO2.9yrsCN¥1.69m데이터 없음
Shao Shao
Supervisorno data데이터 없음데이터 없음
Na Tang
Chairman of Supervisory Board2.9yrs데이터 없음데이터 없음
Guiling Tan
Non-Employee Representative Supervisor7.7yrs데이터 없음데이터 없음
Weidong Zhang
Independent Director3.8yrsCN¥200.00k데이터 없음
Huasheng Huang
Independent Director3.8yrsCN¥200.00k데이터 없음
Li Zhao
Independent Director3.8yrsCN¥200.00k데이터 없음
Kai Qiu
Chairman of the Board1.1yrs데이터 없음데이터 없음
Jinfeng Shen
Director1.1yrs데이터 없음데이터 없음
Jinni Sun
Directorless than a year데이터 없음데이터 없음
Yuxuan Pan
Directorless than a year데이터 없음데이터 없음

2.9yrs

평균 재임 기간

54yo

평균 연령

경험이 풍부한 이사회: 300294 의 이사회경험(평균 재직 기간 2.9 년)으로 간주되지 않으므로 새 이사회가 필요합니다.